Taimoxin-F
Brand names,
Taimoxin-F
Analogs
Taimoxin-F
Brand Names Mixture
Taimoxin-F
Chemical_Formula
C9H13NO2
Taimoxin-F
RX_link
No information avaliable
Taimoxin-F
fda sheet
Taimoxin-F
msds (material safety sheet)
Taimoxin-F
Synthesis Reference
No information avaliable
Taimoxin-F
Molecular Weight
167.205 g/mol
Taimoxin-F
Melting Point
96 oC
Taimoxin-F
H2O Solubility
2500 mg/L
Taimoxin-F
State
Solid
Taimoxin-F
LogP
1.514
Taimoxin-F
Dosage Forms
No information avaliable
Taimoxin-F
Indication
Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.
Taimoxin-F
Pharmacology
Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.
Taimoxin-F
Absorption
Rapidly absorbed following oral administration.
Taimoxin-F
side effects and Toxicity
Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.
Taimoxin-F
Patient Information
Taimoxin-F
Organisms Affected
Humans and other mammals